Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amparo de la Peña

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Clinical Pharmacokinetics|March 31, 2017
No Dose Adjustment is Recommended for Digoxin, Warfarin, Atorvastatin or a Combination Oral Contraceptive When Coadministered with DulaglutideAmparo de la Peña, Xuewei Cui, Jeanne Geiser, et al.
Clinical Pharmacology in Drug Development|February 15, 2018
Tracking the Sugar Rush: Incorporating Continuous Glucose Monitoring Into Multisite Early Clinical Research With Type 2 Diabetes SubjectsSabina Paglialunga, Bruce H Morimoto, Amparo de la Peña, et al.
Diabetes Technology & Therapeutics|July 10, 2007
The AIR inhaled insulin system: system components and pharmacokinetic/glucodynamic dataDouglas B Muchmore, Bernard Silverman, Amparo De La Peña, et al.
Neuropharmacology|June 8, 2025
Reversal of a synthetic opioid overdose: Insights from a validated translational modelCeline M Laffont, Prasad Purohit, Amparo de la Peña, et al.
The AAPS Journal|December 5, 2025
Improvements in Data Quality Can Boost Efficiency and Reduce Development Costs: A Pharmacometric CRO's PerspectiveAmparo de la Peña, Jill Fiedler-Kelly, Rebecca L Humphrey, et al.
Diabetes Technology & Therapeutics|September 24, 2009
AIR insulin capsules of different dose strengths may be combined to yield equivalent pharmacokinetics and glucodynamicsAmparo de la Peña, Mary Seger, Klaus Rave, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 5, 2025
Model-Based Meta-Analysis With MonolixSuite: A Tutorial for Longitudinal Categorical and Continuous DataChloe Bracis, Amit Taneja, Yassine Kamal Lyauk, et al.
Diabetes, Obesity & Metabolism|December 16, 2016
Once-weekly dulaglutide 1.5 mg restores insulin secretion in response to intravenous glucose infusionAmparo de la Peña, Corina Loghin, Xuewei Cui, et al.
Journal of Diabetes Science and Technology|May 31, 2014
Application of PK/PD modeling and simulation to dosing regimen optimization of high-dose human regular U-500 insulinAmparo de la Peña, Xiaosu Ma, Shobha Reddy, et al.
Diabetes Care|January 15, 2008
AIR inhaled insulin versus subcutaneous insulin: pharmacokinetics, glucodynamics, and pulmonary function in asthmaMichael Wolzt, Amparo de la Peña, Pierre-Yves Berclaz, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Clinical Pharmacokinetics|March 31, 2017
No Dose Adjustment is Recommended for Digoxin, Warfarin, Atorvastatin or a Combination Oral Contraceptive When Coadministered with DulaglutideAmparo de la Peña, Xuewei Cui, Jeanne Geiser, et al.
Clinical Pharmacology in Drug Development|February 15, 2018
Tracking the Sugar Rush: Incorporating Continuous Glucose Monitoring Into Multisite Early Clinical Research With Type 2 Diabetes SubjectsSabina Paglialunga, Bruce H Morimoto, Amparo de la Peña, et al.
Diabetes Technology & Therapeutics|July 10, 2007
The AIR inhaled insulin system: system components and pharmacokinetic/glucodynamic dataDouglas B Muchmore, Bernard Silverman, Amparo De La Peña, et al.
Neuropharmacology|June 8, 2025
Reversal of a synthetic opioid overdose: Insights from a validated translational modelCeline M Laffont, Prasad Purohit, Amparo de la Peña, et al.
The AAPS Journal|December 5, 2025
Improvements in Data Quality Can Boost Efficiency and Reduce Development Costs: A Pharmacometric CRO's PerspectiveAmparo de la Peña, Jill Fiedler-Kelly, Rebecca L Humphrey, et al.
Diabetes Technology & Therapeutics|September 24, 2009
AIR insulin capsules of different dose strengths may be combined to yield equivalent pharmacokinetics and glucodynamicsAmparo de la Peña, Mary Seger, Klaus Rave, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 5, 2025
Model-Based Meta-Analysis With MonolixSuite: A Tutorial for Longitudinal Categorical and Continuous DataChloe Bracis, Amit Taneja, Yassine Kamal Lyauk, et al.
Diabetes, Obesity & Metabolism|December 16, 2016
Once-weekly dulaglutide 1.5 mg restores insulin secretion in response to intravenous glucose infusionAmparo de la Peña, Corina Loghin, Xuewei Cui, et al.
Journal of Diabetes Science and Technology|May 31, 2014
Application of PK/PD modeling and simulation to dosing regimen optimization of high-dose human regular U-500 insulinAmparo de la Peña, Xiaosu Ma, Shobha Reddy, et al.
Diabetes Care|January 15, 2008
AIR inhaled insulin versus subcutaneous insulin: pharmacokinetics, glucodynamics, and pulmonary function in asthmaMichael Wolzt, Amparo de la Peña, Pierre-Yves Berclaz, et al.
Pageof 3